103 related articles for article (PubMed ID: 21539687)
41. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
42. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
[TBL] [Abstract][Full Text] [Related]
43. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
[TBL] [Abstract][Full Text] [Related]
44. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
[TBL] [Abstract][Full Text] [Related]
45. Treatment effectiveness and adherence in patients with schizophrenia treated with risperidone long-acting injection.
Chang CL; Tzeng DS; Lung FW
Psychiatry Res; 2010 Nov; 180(1):16-9. PubMed ID: 20488552
[TBL] [Abstract][Full Text] [Related]
46. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system.
Dassa D; Boyer L; Benoit M; Bourcet S; Raymondet P; Bottai T
Aust N Z J Psychiatry; 2010 Oct; 44(10):921-8. PubMed ID: 20932206
[TBL] [Abstract][Full Text] [Related]
47. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.
Rathbun RC; Farmer KC; Stephens JR; Lockhart SM
Clin Ther; 2005 Feb; 27(2):199-209. PubMed ID: 15811483
[TBL] [Abstract][Full Text] [Related]
48. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
[TBL] [Abstract][Full Text] [Related]
49. Relational agents as an adjunct in schizophrenia treatment.
Puskar K; Schlenk EA; Callan J; Bickmore T; Sereika S
J Psychosoc Nurs Ment Health Serv; 2011 Aug; 49(8):22-9. PubMed ID: 21766736
[TBL] [Abstract][Full Text] [Related]
50. Rebelliousness in patients suffering from schizophrenia-spectrum disorders--a possible predictor of attitudes towards medication.
Nitzan U; Bukobza G; Aviram S; Fennig S; Lev-Ran S; Braw Y; Bloch Y
Psychiatry Res; 2013 Oct; 209(3):297-301. PubMed ID: 23352744
[TBL] [Abstract][Full Text] [Related]
51. Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications.
Abdel Aziz K; Elamin MH; El-Saadouni NM; El-Gabry DA; Barakat M; Alhayyas F; Moselhy HF
Int J Soc Psychiatry; 2016 Dec; 62(8):719-725. PubMed ID: 27815512
[TBL] [Abstract][Full Text] [Related]
52. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study.
Doró P; Benko R; Czakó A; Matuz M; Thurzó F; Soós G
Int J Clin Pharm; 2011 Aug; 33(4):690-5. PubMed ID: 21691882
[TBL] [Abstract][Full Text] [Related]
53. Levels of patient activation among adults with schizophrenia: associations with hope, symptoms, medication adherence, and recovery attitudes.
Kukla M; Salyers MP; Lysaker PH
J Nerv Ment Dis; 2013 Apr; 201(4):339-44. PubMed ID: 23538980
[TBL] [Abstract][Full Text] [Related]
54. Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.
Herz MI; Szymanski HV; Simon JC
Am J Psychiatry; 1982 Jul; 139(7):918-22. PubMed ID: 6124133
[TBL] [Abstract][Full Text] [Related]
55. Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis.
Gorczynski P; Firth J; Stubbs B; Rosenbaum S; Vancampfort D
Psychiatry Res; 2017 Apr; 250():17-24. PubMed ID: 28135643
[TBL] [Abstract][Full Text] [Related]
56. A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephones.
Galloway GP; Coyle JR; Guillén JE; Flower K; Mendelson JE
J Addict Med; 2011 Sep; 5(3):170-4. PubMed ID: 21844832
[TBL] [Abstract][Full Text] [Related]
57. Effects of the Nursing Psychoeducation Program on the Acceptance of Medication and Condition-Specific Knowledge of Patients with Schizophrenia.
Matsuda M; Kohno A
Arch Psychiatr Nurs; 2016 Oct; 30(5):581-6. PubMed ID: 27654241
[TBL] [Abstract][Full Text] [Related]
58. Medication-taking behaviours in chronic kidney disease with multiple chronic conditions: a meta-ethnographic synthesis of qualitative studies.
Bartlett Ellis RJ; Welch JL
J Clin Nurs; 2017 Mar; 26(5-6):586-598. PubMed ID: 27648739
[TBL] [Abstract][Full Text] [Related]
59. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence.
Dolder CR; Lacro JP; Warren KA; Golshan S; Perkins DO; Jeste DV
J Clin Psychopharmacol; 2004 Aug; 24(4):404-9. PubMed ID: 15232332
[TBL] [Abstract][Full Text] [Related]
60. Measuring Medication Adherence in Patients With Schizophrenia: An Integrative Review.
Bright CE
Arch Psychiatr Nurs; 2017 Feb; 31(1):99-110. PubMed ID: 28104068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
